性别对类风湿关节炎超声疗效评估的影响:GENUS研究
GENUS研究为多中心前瞻性观察研究,纳入185例起始或换用靶向治疗的类风湿关节炎(RA)患者,男女按年龄匹配。基线及3个月时盲法评估临床、实验室及超声指标,结果显示男女在超声全局评分变化上无显著差异,提示短期超声评估的靶向治疗反应在男女间相似。
要点
- 男女RA患者靶向治疗3个月时超声滑膜炎评分均显著改善(p<0.01)。
- 3个月时男女间临床、实验室及超声变量变化无显著差异(p>0.05)。
- 多变量回归校正混杂因素后,男女超声评分仍无显著差异(p>0.05)。
核心结论
- RA患者靶向治疗短期超声评估的反应在女性和男性之间相似。
研究设计与样本
- GENUS为多中心、观察性、前瞻性研究,纳入185例起始或换用靶向治疗的RA患者,男女按年龄匹配,基线及3个月盲法评估临床、实验室和超声。
主要发现
- 3个月时174例完成评估,男女多数临床、实验室及超声变量较基线显著改善(p<0.01),多数变量效应量大(Wilcoxon符号秩检验r≥0.5)。
- 3个月时男女间临床、实验室及超声变量变化无显著差异(p>0.05),所有变量效应量小(Wilcoxon秩和检验r<0.2)。
- 多变量回归分析校正潜在混杂因素后,男女超声评分无显著差异(p>0.05)。
临床怎么用
- 短期超声评估靶向治疗反应时无需因性别差异调整预期。
局限性
- 11例失访,随访仅3个月,为观察性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess whether the ultrasound-measured response to targeted therapy in rheumatoid arthritis (RA) differs between women and men. METHODS: . The GENder on UltraSound (GENUS) was a multicentre, observational, prospective study. We included RA patients who initiated or switched targeted therapy, gender-balanced and women and men matched by age. Blinded clinical, laboratory, and ultrasound assessments were performed at baseline and three months. We obtained global scores for B-mode synovitis, Doppler synovitis, and the Global EULAR-OMERACT Synovitis Score. The primary outcome was the change in global ultrasound scores from baseline to three months after initiation or switching of targeted therapy. RESULTS: . A total of 185 patients were included [92 (49.7%) women, 93 (50.3%) men]. At three months, 174 patients [90 (51.7%) women, 84 (48.3%) men] were evaluated, while 11 patients were lost to follow-up. Most clinical, laboratory, and ultrasound variables showed significant improvement from baseline to three months in both women and men (p < 0.01), with a large effect size (Wilcoxon signed-rank test r ≥ 0.5) for most variables in both genders. At three months, there were no significant differences in changes in clinical, laboratory, or ultrasound variables between genders (p > 0.05), and the effect size was small (Wilcoxon rank-sum test r < 0.2) for all variables. In multivariate regression analysis, no significant differences in ultrasound scores between women and men were observed after adjustment for potential confounders (p > 0.05). CONCLUSIONS: . These results suggest that the short-term ultrasound-assessed response to targeted therapy in RA patients is similar in women and men.
引用
- Molina-Collada J, Jiménez-Núñez FG, Ortiz-Márquez F, et al. Gender influence on ultrasound-assessed therapeutic response in rheumatoid arthritis: Insights from the GENder on UltraSound (GENUS) study. Semin Arthritis Rheum. 2026. PMID: 42143452. doi:10.1016/j.semarthrit.2026.152993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。